Delivery Order SPE2DB22D1106-SPE2DB25FFFU5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.20 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical distributor will perform this delivery order from its corporate office location...
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,331.75 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,454.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,784.75 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of May 9, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $121,404.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a non-set-aside, competitively awarded procurement with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $3,038.83 under a firm fixed-price contract type. The award, issued on August 28, 2025, represents a non-competitive, competitively awarded delivery order with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $13,771.20. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFU5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.13 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a routine pharmaceutical procurement executed through open competition without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Lidocaine patches represents a typical small-value transaction supporting the Defense Health Agency and other federal healthcare systems through DLA's established pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/28/25 |